Tomoyoshi Shigematsu - Neurosurgery | Mount Sinai

Biography

Specialties

Neurosurgery

Research Topics

Stroke

Education

MD, Osaka University

Residency, Neurosurgery, Osaka University Hospital - Suita

Residency, Neurosurgery, Osaka Neurological Institute

Residency, Neurosurgery, Kobe City Medical Center General Hospital

Fellowship, Endovascular Surgical Neuroradiology, Osaka University Hospital - Suita

Fellowship, Neurosurgery, Icahn School Of Medicine At Mount Sinai

Certifications

American Board of Neurological Surgery

Publications

38

Publications

Selected Publications

Safety and efficacy of dual lumen balloon catheters for the Treatment of cerebral vascular malformations: A systematic review, pooled analysis, and meta-analysis. Stavros Matsoukas, Neha Siddiqui, Jacopo Scaggiante, Devin V. Bageac, Tomoyoshi Shigematsu, Reade DeLeacy, J. Mocco, Shahram Majidi, Christopher P. Kellner, Johanna T. Fifi. Neuroradiology Journal

Evolution of transvenous embolization in vein of Galen malformation: Case series and review of the literature. Johanna T. Fifi, Maximilian Jeremy Bazil, Stavros Matsoukas, Tomoyoshi Shigematsu, Michelle Sorscher, Alejandro Berenstein. Journal of NeuroInterventional Surgery

Percutaneous sclerotherapy of microcystic lymphatic malformations: the use of an innovative gravity-dependent technique. Alejandro Berenstein, Maximilian Jeremy Bazil, Michelle Sorscher, Francine Blei, Reade De Leacy, Tomoyoshi Shigematsu, Milton Waner, Johanna T. Fifi. Journal of NeuroInterventional Surgery

View All Publications

Office Locations

Klingenstein Clinical Center Floor 1 Room 1-North

1450 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Shigematsu during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Shigematsu during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.